GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (STU:NOTA) » Definitions » Median PS Value

Novartis AG (STU:NOTA) Median PS Value : €88.15 (As of Oct. 31, 2024)


View and export this data going back to . Start your Free Trial

What is Novartis AG Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Novartis AG's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was €22.33. Novartis AG's 10-Year median PS Ratio is 3.9476. Therefore, the Median PS Value for today is €88.15.

As of today (2024-10-31), Novartis AG's share price is €101.50. Novartis AG's Median PS Value is €88.15. Therefore, Novartis AG's Price to Median PS Value for today is 1.15.

The historical rank and industry rank for Novartis AG's Median PS Value or its related term are showing as below:

STU:NOTA' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.99   Med: 1.2   Max: 1.53
Current: 1.15

During the past 13 years, the highest Price to Median PS Value of Novartis AG was 1.53. The lowest was 0.99. And the median was 1.20.

STU:NOTA's Price-to-Median-PS-Value is ranked worse than
69.16% of 509 companies
in the Drug Manufacturers industry
Industry Median: 0.88 vs STU:NOTA: 1.15

Novartis AG Median PS Value Historical Data

The historical data trend for Novartis AG's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Median PS Value Chart

Novartis AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 61.32 61.30 61.02 77.27 80.45

Novartis AG Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 76.52 80.45 79.52 83.98 88.22

Competitive Comparison of Novartis AG's Median PS Value

For the Drug Manufacturers - General subindustry, Novartis AG's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis AG's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Novartis AG's Price-to-Median-PS-Value falls into.



Novartis AG Median PS Value Calculation

Novartis AG's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=22.33*3.9476
=88.15

10-Year Median PS Ratio is 3.9476.
Novartis AG's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €22.33.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novartis AG  (STU:NOTA) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Novartis AG's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=101.50/88.15
=1.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novartis AG Median PS Value Related Terms

Thank you for viewing the detailed overview of Novartis AG's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis AG Business Description

Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Novartis AG Headlines

No Headlines